U.S. CDMRP – Melanoma Research Program (MRP)
Event details
| Date | 30.06.2025 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2025 Melanoma Research Program (MRP). Several award programs are available:
Funding:
Focused Program Award - Rare Melanomas: $2.8M
Idea Award: $560,000
Survivorship Research Award: $1,015,000
Team Science Award: $2.1M
Duration:
Focused Program Award - Rare Melanomas: 4 years
Idea Award: 2 years
Survivorship Research Award: 3 years
Team Science Award: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline:
Focused Program Award - Rare Melanomas: 30 June 2025, 5:00 p.m. Eastern time
Idea Award: 30 June 2025, 5:00 p.m. Eastern time
Team Science Award: 30 June 2025, 5:00 p.m. Eastern time
Survivorship Research Award: 10 September 2025, 5:00 p.m. Eastern time
Full Application Deadline:
01 October 2025, 5:00 p.m. Eastern time
Further information:
- The Focused Program Award - Rare Melanomas is intended to support a multidisciplinary research program of at least two, but not more than three, distinct but complementary projects addressing an overarching question relevant to rare melanomas. Applications for the FPA-RM may propose projects across the entire research spectrum (biology, etiology, prevention, diagnosis and detection, prognosis, treatment, and quality of life) and must address a critical unmet need relevant to rare melanomas.
- The Idea Award aims to generate novel research avenues for investigation; therefore, novelty and innovation should be key aspects of the proposed project. Research supported by the Idea Award must introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other highly creative qualities. The proposed project must be exploratory, hypothesis-driven, or hypothesisgenerating research and be based on a well-developed study design and plan of analysis. PIs new to the melanoma field are encouraged to apply. All applications must specifically address at least one of the Focus Areas listed in this document.
- The Survivorship Research Award is intended to address the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families, and/or their caregivers (Figure 1). Applications may propose development of evidence-based practices, behavioral health science and survivor and/or caregiver well-being interventions and surveillance, and/or identification of psychosocial survivor outcomes. Clinical trials are allowed.
- Team Science Award is intended to bring together investigators from divergent disciplines to achieve innovations and advancements in melanoma research and/or patient care that could not be achieved by any one investigator working independently. While basic research is allowed, all applications are expected to articulate the short- and long-term benefits of the expected research outcomes for the melanoma patient community. All applications must specifically address at least one of the Focus Areas listed in this document.
Funding:
Focused Program Award - Rare Melanomas: $2.8M
Idea Award: $560,000
Survivorship Research Award: $1,015,000
Team Science Award: $2.1M
Duration:
Focused Program Award - Rare Melanomas: 4 years
Idea Award: 2 years
Survivorship Research Award: 3 years
Team Science Award: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline:
Focused Program Award - Rare Melanomas: 30 June 2025, 5:00 p.m. Eastern time
Idea Award: 30 June 2025, 5:00 p.m. Eastern time
Team Science Award: 30 June 2025, 5:00 p.m. Eastern time
Survivorship Research Award: 10 September 2025, 5:00 p.m. Eastern time
Full Application Deadline:
01 October 2025, 5:00 p.m. Eastern time
Further information:
- To find the full program announcements and to start your pre-application see here
- A useful summary of each call can be found here
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
- Grants.gov Funding Opportunity Numbers:
- Focused Program Award - Rare Melanomas: HT942525MRPFPARM
- Idea Award: HT942525MRPIA
- Survivorship Research Award: HT942525MRPSRA
- Team Science Award: HT942525MRPTSA
Practical information
- General public
- Free
Contact
- research@epfl.ch